CNOT12 and viral infectious disease: In the presence of bortezomib, the degradation of Tab182 and MRE11 following viral infection was reduced but not completely inhibited; in the absence of the proteasome inhibitor (DMSO), the proteins were degraded in the presence of the viruses (Fig. 6).